Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Marsh

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|April 1, 1994
Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplastyJ J Ferguson, K G Dougherty, C M Gaos, et al.
Journal of Medicinal Chemistry|November 5, 1997
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonistsH S Jae, M Winn, D B Dixon, et al.
British Journal of Pharmacology|June 3, 2008
Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeysJ J Lynch, A W Wilson, L E Hernandez, et al.
Psychopharmacology|April 1, 1997
Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418M A Prendergast, A V Terry, W J Jackson, et al.
Journal of Medicinal Chemistry|November 2, 2001
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonistsH S Jae, M Winn, T W von Geldern, et al.
Biochemical and Biophysical Research Communications|June 6, 1995
Potent inhibitors of the HIV-1 protease with good oral bioavailabilitiesH L Sham, C Zhao, K C Marsh, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ET(B) antagonists containing a diphenylmethylamine acetamide side chainG Liu, N S Kozmina, M Winn, et al.
Journal of Medicinal Chemistry|February 5, 1993
Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolD J Kempf, L Codacovi, X C Wang, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Design of orally bioavailable, symmetry-based inhibitors of HIV proteaseD J Kempf, K C Marsh, L C Fino, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivityA A Hancock, M E Brune, D G Witte, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|April 1, 1994
Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplastyJ J Ferguson, K G Dougherty, C M Gaos, et al.
Journal of Medicinal Chemistry|November 5, 1997
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonistsH S Jae, M Winn, D B Dixon, et al.
British Journal of Pharmacology|June 3, 2008
Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeysJ J Lynch, A W Wilson, L E Hernandez, et al.
Psychopharmacology|April 1, 1997
Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418M A Prendergast, A V Terry, W J Jackson, et al.
Journal of Medicinal Chemistry|November 2, 2001
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonistsH S Jae, M Winn, T W von Geldern, et al.
Biochemical and Biophysical Research Communications|June 6, 1995
Potent inhibitors of the HIV-1 protease with good oral bioavailabilitiesH L Sham, C Zhao, K C Marsh, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ET(B) antagonists containing a diphenylmethylamine acetamide side chainG Liu, N S Kozmina, M Winn, et al.
Journal of Medicinal Chemistry|February 5, 1993
Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolD J Kempf, L Codacovi, X C Wang, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Design of orally bioavailable, symmetry-based inhibitors of HIV proteaseD J Kempf, K C Marsh, L C Fino, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivityA A Hancock, M E Brune, D G Witte, et al.
Pageof 5